Advocate Sushila
DELHI HIGH COURT GRANTS INJUNCTION AGAINST PATENT INFRINGEMENT OF A PHARMACEUTICAL PRODUCT
Advocate Sushila Ram 10 Jul 2021

DELHI HIGH COURT GRANTS INJUNCTION AGAINST PATENT INFRINGEMENT OF A PHARMACEUTICAL PRODUCT

The #DelhiHighCourt Single Judge Bench comprising J. C. Hari Shankar, has recently passed a #Judgment dated 07-07-2021 in FMC Corporation & Anr vs Best Crop Science LLP & Anr and granted #injunction against #infringement of the Plaintiff’s registered #patent.


In this case, the Plaintiff, FMC Corporation, asserted that it has obtained patent relating to a product, namely, Chlorantraniliprole (also known as “CTPR”) (Patented Product) and the process for the preparation thereof (Patented Process). The Plaintiff asserted that the compounds in the Patented Product are first of a kind, novel insecticides. CTPR has also been registered with the Central Insecticides Board in India. Further, the Plaintiff claimed to have obtained Patent for this Product and Process in several countries including India. Hence, the Plaintiff claimed exclusive rights to manufacture, use, market or sell CTPR in India and that a third party cannot manufacture, sell or distribute CTPR in India without a valid license from the Plaintiff.


To read more, please visit the link below:


https://theindianlawyer.in/delhi-high-court-grants-injunction-against-patent-infringement-of-a-pharmaceutical-product/


#delhihighcourt #injunction #patent #infringement #pharma

Did you find this write up useful? YES 0 NO 0
Featured Members view all

New Members view all

×

C2RMTo Know More

Something Awesome Is In The Work

0

DAYS

0

HOURS

0

MINUTES

0

SECONDS

Sign-up and we will notify you of our launch.
We’ll also give some discount for your effort :)

* We won’t use your email for spam, just to notify you of our launch.